Bay Area - Bristol Myers Squibb

Transforming scientific curiosity into prolific innovation in the Bay Area: 

See how our R&D teams in the Bay Area make important strides in research and early clinical development across oncology, hematology, immunology and cardiovascular disease.

From landmark discoveries of the first checkpoint inhibitors and development of the first oral cardiac myosin inhibitor to research advancements in cell therapy, targeted protein degradation and the tumor microenvironment, scientists in Brisbane and Redwood City fuel tomorrow’s therapeutic breakthroughs for patients.